MMP Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 18, 2025, 12:06 pm

Competitors of MMP Industries Ltd

All Competitor Stocks of MMP Industries Ltd

Quarterly Result

Last Updated: August 20, 2025, 6:55 am

Below is a detailed analysis of the quarterly data for MMP Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 183.30 Cr.. The value appears to be declining and may need further review. It has decreased from 223.12 Cr. (Mar 2025) to 183.30 Cr., marking a decrease of 39.82 Cr..
• For Expenses, as of Jun 2025, the value is 170.54 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 204.70 Cr. (Mar 2025) to 170.54 Cr., marking a decrease of 34.16 Cr..
• For Operating Profit, as of Jun 2025, the value is 12.76 Cr.. The value appears to be declining and may need further review. It has decreased from 18.42 Cr. (Mar 2025) to 12.76 Cr., marking a decrease of 5.66 Cr..
• For OPM %, as of Jun 2025, the value is 6.96%. The value appears to be declining and may need further review. It has decreased from 8.26% (Mar 2025) to 6.96%, marking a decrease of 1.30%.
• For Other Income, as of Jun 2025, the value is -15.17 Cr.. The value appears to be declining and may need further review. It has decreased from 1.37 Cr. (Mar 2025) to -15.17 Cr., marking a decrease of 16.54 Cr..
• For Interest, as of Jun 2025, the value is 2.60 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.91 Cr. (Mar 2025) to 2.60 Cr., marking a decrease of 0.31 Cr..
• For Depreciation, as of Jun 2025, the value is 2.76 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.55 Cr. (Mar 2025) to 2.76 Cr., marking an increase of 0.21 Cr..
• For Profit before tax, as of Jun 2025, the value is -7.77 Cr.. The value appears to be declining and may need further review. It has decreased from 14.33 Cr. (Mar 2025) to -7.77 Cr., marking a decrease of 22.10 Cr..
• For Tax %, as of Jun 2025, the value is -30.37%. The value appears to be improving (decreasing) as expected. It has decreased from 24.21% (Mar 2025) to -30.37%, marking a decrease of 54.58%.
• For Net Profit, as of Jun 2025, the value is -5.41 Cr.. The value appears to be declining and may need further review. It has decreased from 10.86 Cr. (Mar 2025) to -5.41 Cr., marking a decrease of 16.27 Cr..
• For EPS in Rs, as of Jun 2025, the value is -2.13. The value appears to be declining and may need further review. It has decreased from 4.28 (Mar 2025) to -2.13, marking a decrease of 6.41.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:51 am

Balance Sheet

Last Updated: November 9, 2025, 2:31 pm

Below is a detailed analysis of the balance sheet data for MMP Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
• For Reserves, as of Sep 2025, the value is 295.00 Cr.. The value appears to be declining and may need further review. It has decreased from 298.00 Cr. (Mar 2025) to 295.00 Cr., marking a decrease of 3.00 Cr..
• For Borrowings, as of Sep 2025, the value is 173.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 156.00 Cr. (Mar 2025) to 173.00 Cr., marking an increase of 17.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 68.00 Cr.. The value appears to be improving (decreasing). It has decreased from 69.00 Cr. (Mar 2025) to 68.00 Cr., marking a decrease of 1.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 562.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 549.00 Cr. (Mar 2025) to 562.00 Cr., marking an increase of 13.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 237.00 Cr.. The value appears strong and on an upward trend. It has increased from 223.00 Cr. (Mar 2025) to 237.00 Cr., marking an increase of 14.00 Cr..
• For CWIP, as of Sep 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 28.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 1.00 Cr..
• For Investments, as of Sep 2025, the value is 52.00 Cr.. The value appears strong and on an upward trend. It has increased from 48.00 Cr. (Mar 2025) to 52.00 Cr., marking an increase of 4.00 Cr..
• For Other Assets, as of Sep 2025, the value is 244.00 Cr.. The value appears to be declining and may need further review. It has decreased from 250.00 Cr. (Mar 2025) to 244.00 Cr., marking a decrease of 6.00 Cr..
• For Total Assets, as of Sep 2025, the value is 562.00 Cr.. The value appears strong and on an upward trend. It has increased from 549.00 Cr. (Mar 2025) to 562.00 Cr., marking an increase of 13.00 Cr..

Notably, the Reserves (295.00 Cr.) exceed the Borrowings (173.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for MMP Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 15.30. This value is within the healthy range. It has increased from 12.46 (Mar 24) to 15.30, marking an increase of 2.84.
• For Diluted EPS (Rs.), as of Mar 25, the value is 15.30. This value is within the healthy range. It has increased from 12.46 (Mar 24) to 15.30, marking an increase of 2.84.
• For Cash EPS (Rs.), as of Mar 25, the value is 16.71. This value is within the healthy range. It has increased from 12.75 (Mar 24) to 16.71, marking an increase of 3.96.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 127.33. It has increased from 113.76 (Mar 24) to 127.33, marking an increase of 13.57.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 127.33. It has increased from 113.76 (Mar 24) to 127.33, marking an increase of 13.57.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 272.36. It has increased from 227.75 (Mar 24) to 272.36, marking an increase of 44.61.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 25.54. This value is within the healthy range. It has increased from 18.72 (Mar 24) to 25.54, marking an increase of 6.82.
• For PBIT / Share (Rs.), as of Mar 25, the value is 21.72. This value is within the healthy range. It has increased from 15.59 (Mar 24) to 21.72, marking an increase of 6.13.
• For PBT / Share (Rs.), as of Mar 25, the value is 17.70. This value is within the healthy range. It has increased from 12.89 (Mar 24) to 17.70, marking an increase of 4.81.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 12.89. This value is within the healthy range. It has increased from 9.61 (Mar 24) to 12.89, marking an increase of 3.28.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 15.30. This value is within the healthy range. It has increased from 12.46 (Mar 24) to 15.30, marking an increase of 2.84.
• For PBDIT Margin (%), as of Mar 25, the value is 9.37. This value is below the healthy minimum of 10. It has increased from 8.22 (Mar 24) to 9.37, marking an increase of 1.15.
• For PBIT Margin (%), as of Mar 25, the value is 7.97. This value is below the healthy minimum of 10. It has increased from 6.84 (Mar 24) to 7.97, marking an increase of 1.13.
• For PBT Margin (%), as of Mar 25, the value is 6.50. This value is below the healthy minimum of 10. It has increased from 5.66 (Mar 24) to 6.50, marking an increase of 0.84.
• For Net Profit Margin (%), as of Mar 25, the value is 4.73. This value is below the healthy minimum of 5. It has increased from 4.22 (Mar 24) to 4.73, marking an increase of 0.51.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.61. This value is below the healthy minimum of 8. It has increased from 5.46 (Mar 24) to 5.61, marking an increase of 0.15.
• For Return on Networth / Equity (%), as of Mar 25, the value is 12.01. This value is below the healthy minimum of 15. It has increased from 10.94 (Mar 24) to 12.01, marking an increase of 1.07.
• For Return on Capital Employeed (%), as of Mar 25, the value is 14.67. This value is within the healthy range. It has increased from 12.46 (Mar 24) to 14.67, marking an increase of 2.21.
• For Return On Assets (%), as of Mar 25, the value is 7.08. This value is within the healthy range. It has decreased from 7.27 (Mar 24) to 7.08, marking a decrease of 0.19.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.09. This value is below the healthy minimum of 0.2. It has increased from 0.04 (Mar 24) to 0.09, marking an increase of 0.05.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.48. This value is within the healthy range. It has increased from 0.32 (Mar 24) to 0.48, marking an increase of 0.16.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.41. It has decreased from 1.46 (Mar 24) to 1.41, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 1.5. It has decreased from 1.48 (Mar 24) to 1.39, marking a decrease of 0.09.
• For Quick Ratio (X), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 1. It has increased from 0.53 (Mar 24) to 0.60, marking an increase of 0.07.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.63. This value is within the healthy range. It has increased from 4.70 (Mar 24) to 5.63, marking an increase of 0.93.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 9.80. This value is below the healthy minimum of 20. It has increased from 8.02 (Mar 24) to 9.80, marking an increase of 1.78.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 7.84. This value is below the healthy minimum of 20. It has increased from 6.41 (Mar 24) to 7.84, marking an increase of 1.43.
• For Earning Retention Ratio (%), as of Mar 25, the value is 90.20. This value exceeds the healthy maximum of 70. It has decreased from 91.98 (Mar 24) to 90.20, marking a decrease of 1.78.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 92.16. This value exceeds the healthy maximum of 70. It has decreased from 93.59 (Mar 24) to 92.16, marking a decrease of 1.43.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.36. This value is within the healthy range. It has decreased from 6.95 (Mar 24) to 6.36, marking a decrease of 0.59.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.21. This value is within the healthy range. It has decreased from 4.57 (Mar 24) to 4.21, marking a decrease of 0.36.
• For Enterprise Value (Cr.), as of Mar 25, the value is 802.06. It has increased from 739.58 (Mar 24) to 802.06, marking an increase of 62.48.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.28 (Mar 24) to 1.16, marking a decrease of 0.12.
• For EV / EBITDA (X), as of Mar 25, the value is 12.36. This value is within the healthy range. It has decreased from 15.55 (Mar 24) to 12.36, marking a decrease of 3.19.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has decreased from 1.12 (Mar 24) to 0.94, marking a decrease of 0.18.
• For Retention Ratios (%), as of Mar 25, the value is 90.19. This value exceeds the healthy maximum of 70. It has decreased from 91.97 (Mar 24) to 90.19, marking a decrease of 1.78.
• For Price / BV (X), as of Mar 25, the value is 2.03. This value is within the healthy range. It has decreased from 2.24 (Mar 24) to 2.03, marking a decrease of 0.21.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has decreased from 1.12 (Mar 24) to 0.94, marking a decrease of 0.18.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness